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Abstract
Background: Population-based investigations studying the association between snoring and left ventricular
hypertrophy (LVH) are lacking. Therefore, our study aims to investigate whether snoring is significantly associated
with LVH, and to make clear the effect of varying degrees of snoring intensity on LVH.
Methods: A total of 10,139 participants were involved in this cross-sectional study. Snoring status and snoring
intensity were evaluated by a structured questionnaire. LVH was defined as left ventricular mass index ≥51 g/m2.7
for both men and women.
Results: The total prevalence of LVH was 10.0 %. the prevalence increased significantly in snorers according to snoring
intensity, including low (10.3 %), normal (13.1 %), strong (14.7 %) and very strong (16.7 %). After adjustment for age, race,
gender, educational status, physical activity, annual income, current smoking status, current drinking status, sleep duration,
hypertension, body mass index, waist circumference, low-density lipoprotein cholesterol, high-density lipoprotein
cholesterol, triglyceride, total cholesterol and fasting plasma glucose, snoring (OR, 1.371; 95 % CI, 1.147–1.637, P < 0.001)
was significantly associated with LVH. In addition, among the four kinds of intensity of snoring, normal (OR, 1.436; 95 % CI,
1.126–1.832, P = 0.004), strong (OR, 1.462; 95 % CI, 1.124–1.902, P < 0.001) and very strong (OR, 1.813; 95 % CI, 1.273–2.684,
P < 0.001), rather than low (OR, 1.094; 95 % CI, 0.834–1.434, P = 0.518) were significantly associated with LVH.
Conclusions: Snoring is independently associated with LVH. What’s more, with the rise in snoring intensity, snoring will
exert an increasing effect on LVH.
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Background
Snoring is a loud and jarring noise produced by the joint
vibration of tongue and soft palate as a result of the
obstructed breathing while sleeping. It is believed to be
an important manifestation of obstructive sleep apnea
(OSA). Exceptionally, however, still 40 % male snorers
and 20 % female snorers do not experience OSA [1, 2].
In addition, lots of studies in recent years showed that
snoring was significantly associated with cardiovascular
disease (CVD) [3–6].
There are many possible causes to CVD. Studies have
verified that snoring is closely linked to metabolic syn-
drome [7, 8] which has always been considered as an
important independent risk factor of CVD [9, 10].
Therefore, it is probable that metabolic syndrome medi-
ates the connection between snoring and CVD. Athero-
sclerotic plaque is another probable way of mediating
the connection between snoring and CVD, for recent
studies have verified that snoring is closely associated
with atherosclerosis [11, 12].
Having been long considered as an important risk fac-
tor of CVD [13, 14], left ventricular hypertrophy (LVH)
is closely linked to myocardial infarction, stroke and
arrhythmia [15]. Is there possibility that it is by mediat-
ing LVH that snoring results in CVD? As far as we
know, there hasn’t been any relevant studies to explore
whether or not snoring is significantly associated with
LVH in the general population. Besides, most previous
studies, which estimated the effect of snoring on CVD,
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always focused on snoring frequency, but few studied
the relationship between snoring and CVD by grading
the snoring intensity. Hence, our study intend to ascer-
tain whether snoring is significantly associated with
LVH, and to make clear the the effect of varying degrees
of snoring intensity on LVH.
Methods
Study population
The study was conducted from January 2012 to August
2013. A representative sample from the participants aged
over 35 years old was selected to present the prevalence,
incidence and natural history of cardiovascular risk fac-
tors in rural areas of Liaoning Province. The study
adopted a multi-stage, stratified, random-cluster sam-
pling scheme. At the first stage, three areas of Dawa,
Zhangwu and Liaoyang County were randomly selected
from Liaoning province. At the second stage, one town
was randomly selected from each county (for a total of
three towns). At the third stage, 8 to 10 rural villages
from each town were randomly selected (for a total of
26 rural villages). A total of 14,016 satisfactory partici-
pants were enrolled in this survey. Among those, 11,956
participants completed this study with a response rate of
85.3 %. And the participants who were pregnant or had
malignant tumors or mental disorders or didn’t know
whether she/he snoring or missing variables for our
multivariable logistic regression models were excluded.
Finally, a sample size of 10,139 is accepted. The study
was approved by the Ethics Committee of China Medical
University, Shenyang, China and all procedures were
conducted under ethical standards. Written consent was
obtained from all participants after they had been in-
formed of the objectives, benefits, medical items and
confidentiality agreement regarding their personal in-
formation. For participants who were illiterate, written
informed consent were obtained from their proxies.
Echocardiography measurements
Echocardiograms were performed on each participants
by professional sonographers with a commercially avail-
able Doppler echocardiograph (Vivid, GE Healthcare,
United States), using a 3.0-MHz transducer. Subjects
should maintain in the supine position and transthoracic
echocardiogram included M-mode, 2-dimensional, spec-
tral and color Doppler. Echocardiogram analyses were
performed by three doctors specialized in echocardi-
ography and consultations were made with two other
doctors if questions or uncertainty arose. M-mode and
two-dimensional images of the left ventricular (LV) wall
thickness, internal diameter, aortic root and left atrium
was being recorded by eath participants’ parasternal
acoustic window. Correct orientation of planes for
Doppler recordings and imagings were verified according
to previously described procedures [16, 17]. LV internal
dimensions (LVID), posterior wall thickness (PWT) and
interventricular septal thickness (IVST) were obtained
according to American Society of Echocardiography
recommendations [17, 18]. Left ventricular mass was
calculated according to the formula LVM [19] =0.81
(1.04 [LVID + IVST + PWT]) 3 - (LVID) 3 + 0.06. Ac-
cording to de Simone et al, Left ventricular mass
index (LVMI) was normalized for body height in m2.7
[20]. LVH was defined as the LVMI ≥51 g/m2.7 for
both men and women [20].
Covariate measurements and definitions
Information on covariates, such as demographic char-
acteristics, lifestyle risk factors, family income and
family history of chronic diseases, was collected dur-
ing a single clinic visit by cardiologists and trained
nurses using a standard questionnaire by face-to-face
interview. Before the survey was performed, we in-
vited all eligible investigators to attend the organized
training. The training contents included the purpose
of this study, how to administer the questionnaire,
the standard method of measurement, the importance
of standardization, and the study procedures. A strict
test was evaluated after this training, only those who
scored perfectly on the test could become investiga-
tors. During data collection, our inspectors had fur-
ther instructions and support.
Race was categorized as Han or others which included
some ethnic minorities in China, such as Mongol and
Manchu. The questions posed for the educational level
were categorized as primary school or below, middle
school and high school or above. Sleep duration were
self-reported from the participants by asking the follow-
ing question, ‘How many hours of sleep do you usually
have everyday on average (including nocturnal sleep dur-
ation and nap duration)? Family income was categorized
into three groups ≤5000, 5000–20,000 and >20,000
CNY/year. Current drinking status was defined as one
or more alcoholic drinks in the previous year. Current
smoking status was defined as a history of 100 or more
cigarettes and continued use.
Physical activity which included occupational and
leisure-time physical activity, was evaluated by a de-
tailed description [21]. Occupational and leisure-time
physical activity were merged and regrouped into 3
categories: 1) low was defined as participants who re-
ported light levels of both occupational and leisure-
time physical activity, 2) moderate was defined as
participants who reported moderate or high levels of
either occupational or leisure-time physical activity,
3) high was defined as participants who reported a
moderate or high level of both occupational and
leisure-time physical activity.
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According to American Heart Association protocol,
blood pressure (BP) which was measured three times at
two-min intervals after more than 10 min of rest, was
measured by a standardized automatic electronic sphyg-
momanometer (HEM-907; Omron, Japan). Caffeinated
beverages and exercise should be avoided for at least
30 min before the measurement. With the arm sup-
ported at the level of the heart, the participants were
seated appropriately during the measurement. The mean
of three blood pressure (BP) measures which was calcu-
lated accurately, was used in all analyses. And hyperten-
sion was defined as BP ≥140/90 mmHg or currently
taking hypertension medication, according to JNC-7 re-
port guidelines [22].
Fasting blood samples were collected after 12 h of fast-
ing in the morning. Blood samples were obtained from
an antecubital vein into vacutainer tubes containing
ethylenediaminetetraacetic acid (EDTA). Enzymatic re-
action was used to analyze blood samples inculding
fasting plasma glucose (FPG), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), triglyceride (TG), total cholesterol (TC) and
other routine blood biochemical indexes on an Olympus
AU640 autoanalyzer (Olympus, Kobe, Japan). All labora-
tory equipments were calibrated, and all blinded duplicate
samples were used in our study.
Information on snoring
Snoring status was evaluated by a structured question-
naire, including two questions: 1, Do you know, or some-
one tell you that you snore? (yes or no or don’t know);
and 2, How much is the loudness of sound when you are
snoring? (Slightly louder than breathing sound = 1; as loud
as speaking = 2; louder than normal speaking = 3; so loud
that it can be heard in the next room = 4). According to
the question 2, snoring intensity were categorized into
low, normal, strong and very strong respectively.
These responses were either self-reported or the re-
sponse of a close relative and this method had been
widely used to obtain the information of snoring, es-
pecially in epidemiologic studies [3–6, 11, 12].
Statistical Analysis
Data were expressed as mean ± standard deviation (SD)
for continuous variables and numbers (percentages) for
categorical variables. Differences in the characteristics of
study participants between snorers and non-snorers
were determined utilizing the t-test, ANOVA, non-
parametric test or the χ2-test, as appropriate. LVH was
evaluated with multivariate logistic regression analyses
according to snoring and its intensity. Adjustments for
potential confounders were as follows: Model 1 = un-
adjusted; Model 2 = adjusted for age, race, gender, educa-
tional status, physical activity, annual income, current
smoking status, current drinking status and sleep dur-
ation; Model 3 =model 2 plus hypertension, waist circum-
ference, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, triglyceride, total cholesterol and
fasting plasma glucose. Results of logistic regression ana-
lyses are reported as odds ratios (ORs) and corresponding
95 % confidence intervals (CIs). All the statistical analyses
were calculated using programs available in the SPSS ver-
sion 22.0 software (IBM Corp., Armonk, NY, USA), and P
values were considered to be statistically significant if less
than 0.05.
Results
Baseline characteristics of participants between snorers
and non-snorers
A total of 10,139 participants were involved in this
cross-sectional study. the prevalence of snoring was
42.2 % (n = 4275) and the prevalence of four kinds of
snoring intensity including low, normal, strong and very
strong was 13.9 % (n = 1412), 14.3 % (n = 1450), 10.4 %
(n = 1059) and 3.5 % (n = 354) respectively (Fig. 1). Com-
pared with non-snorers, snorers were significantly older
and had higher levels of systolic blood pressure, diastolic
blood pressure, body mass index, height, waist circum-
ference, low-density lipoprotein cholesterol, triglyceride,
total cholesterol and the prevalence of current smoking,
drinking, diabetes and hypertension (Table 1) (all Ps < 0.05).
However, there was no significant difference between the
Fig. 1 Prevalence of different snoring intensity. The prevalence of
each kinds of snoring intensity including low, normal, strong and
very strong was 13.9, 14.3, 10.4 and 3.5 % respectively
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two groups in race, sleep duration and levels of educational
status, physical activity and annual income.
Echocardiographic characteristics of participants
according to snoring status
As the results showed in Table 2, compared with non-
snorers, snorers had significantly higher levels of LVID,
IVST, PWT, left atrial dimension (LAD), left ventricular
mass, left ventricular mass index and prevalence of left
ventricular hypertrophy, and lower levels of early/late
diastolic peak flow velocity (E/A) (all Ps < 0.05). How-
ever, there was no significant difference between the two
groups in RWT and ejection fraction (EF).
The prevalence of LVH by different grades of the snoring
intensity
The total prevalence of LVH was 10.0 % and the preva-
lence of LVH in non-snorers was 7.9 %. The prevalence
increased significantly in snorers according to snoring
intensity, including low (10.3 %), normal (13.1 %), strong
(14.7 %) and very strong (16.7 %) (Fig. 2).
In Table 3, we estimated the ORs between snoring and
LVH. Unadjusted in model 1, snoring (OR, 1.734; 95 %
CI, 1.522–1.976, P < 0.001) was significantly associated
with LVH. Among the four kinds of intensity of snoring,
low (OR, 1.352; 95 % CI, 1.111–1.644, P = 0.003), normal
(OR, 1.767; 95 % CI, 1.477–2.115, P < 0.001), strong
Table 1 Characteristics of participants according to snoring status
Variables Non-snorers Snorers P-value
Mean ± SD
Age (year) 53.3 ± 10.9 54.5 ± 9.9 <0.001
Male gender (%) 2475 (42.2) 2216 (51.8) <0.001
Race (Han) (%) 5572 (95.0) 4067 (95.1) 0.793
Educational status (%) 0.065
Primary school or below 2882 (49.1) 2182 (51.0)
Middle school 2448 (41.7) 1686 (39.4)
High school or above 534 (9.1) 407 (9.5)
Physical activity (%) 0.102
Light 1699 (29.0) 1261 (29.5)
Moderate 3852 (65.7) 2747 (64.3)
Severe 313 (5.3) 267 (6.2)
Annual income (CNY/year) 0.662
≤ 5000 732 (12.5) 520 (12.2)
5000–20000 3161 (53.9) 2343 (54.8)
> 20000 1971 (33.6) 1412 (33.0)
Current smoking status (%) 1916 (32.7) 1672 (39.1) <0.001
Current drinking status (%) 1155 (19.7) 1139 (26.6) <0.001
Sleep duration (h/d) 7.2 ± 1.7 7.3 ± 1.7 0.069
Systolic blood pressure (mmHg) 138.9 ± 22.8 145.0 ± 23.3 <0.001
Diastolic blood pressure (mmHg) 80.6 ± 11.2 83.8 ± 12.0 <0.001
Height (cm) 160.5 ± 8.0 161.4 ± 8.3 <0.001
Body mass index (kg/m2) 24.1 ± 3.4 25.7 ± 3.8 <0.001
Waist circumference (cm) 80.3 ± 9.3 85.2 ± 9.9 <0.001
Low-density lipoprotein cholesterol (mmol/L) 2.9 ± 0.8 3.0 ± 0.8 <0.001
High-density lipoprotein cholesterol (mmol/L) 1.4 ± 0.4 1.4 ± 0.4 <0.001
Triglyceride (mmol/L) 1.5 ± 1.4 1.8 ± 1.6 <0.001
Total cholesterol (mmol/L) 5.2 ± 1.1 5.3 ± 1.1 <0.001
Fasting plasma glucose (mmol/L) 5.8 ± 1.5 6.0 ± 1.7 <0.001
Diabetes (%) 503 (8.6) 533 (12.5) <0.001
Hypertension (%) 2648 (45.2) 2482 (58.1) <0.001
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(OR, 2.025; 95 % CI, 1.666–2.460, P < 0.001) and very
strong (OR, 2.344; 95 % CI, 1.745–3.149, P < 0.001) were
all significantly associated with LVH. After adjustment
for age, race, gender, educational status, physical activity,
annual income, current smoking status, current drinking
status and sleep duration in model 2, snoring (OR,
1.709; 95 % CI, 1.495–1.953, P < 0.001) was significantly
associated with LVH. In addition, among the four kinds of
intensity of snoring, low (OR, 1.381; 95 % CI, 1.131–1.684,
P = 0.002), normal (OR, 1.774; 95 % CI, 1.476–2.133,
P < 0.001), strong (OR, 1.886; 95 % CI, 1.545–2.302,
P < 0.001) and very strong (OR, 2.199; 95 % CI, 1.624–
2.977, P < 0.001) were all significantly associated with
LVH. To farther ascertain the role that metabolic factors
play in this relationship, we adjusted model 2 and intro-
duced hypertension, body mass index, waist circumfer-
ence, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, triglyceride, total cholesterol
and fasting plasma glucose into model 3. Interestingly,
still the increased ORs could be observed in group
snoring (OR, 1.371; 95 % CI, 1.147–1.637, P < 0.001),
normal (OR, 1.436; 95 % CI, 1.126–1.832, P = 0.004),
strong (OR, 1.462; 95 % CI, 1.124–1.902, P < 0.001) and
very strong (OR, 1.813; 95 % CI, 1.273–2.684, P < 0.001)
intensity of snoring, rather than low (OR, 1.094; 95 % CI,
0.834–1.434, P = 0.518) intensity of snoring. But the
ORs were attenuated when we further adjusted for these
metabolic factors.
Fig. 2 Prevalence of left ventricular hypertrophy by different grades of the snoring intensity. The total prevalence of LVH was 10.0 % and the
prevalence of LVH in non-snorers was 7.9 %. The prevalence increased significantly in snorers according to snoring intensity, including low
(10.3 %), normal (13.1 %), strong (14.7 %) and very strong (16.7 %). Abbreviations: LVH = left ventricular hypertrophy
Table 2 Echocardiographic characteristics of participants according to snoring status
Variables Non-snorers Snorers P-value
Mean ± SD
End-diastolic left ventricular internal dimension (LVID), mm 4.7 ± 0.4 4.8 ± 0.4 <0.001
End-diastolic interventricular septum thickness (IVST), mm 0.9 ± 0.3 1.0 ± 0.2 <0.001
End-diastolic posterior wall thickness (PWT), mm 0.9 ± 0.3 1.0 ± 0.2 <0.001
Myocardial relative wall thickness (RWT), mm 0.4 ± 0.1 0.4 ± 0.1 0.074
Left atrial dimension (LAD) (mm) 3.3 ± 0.4 3.4 ± 0.4 <0.001
Ejection fraction (EF), (%) 63.0 ± 3.8 62.9 ± 3.8 0.192
Early/late diastolic peak flow velocity (E/A) ratio 1.1 ± 0.5 1.0 ± 1.5 0.012
Left ventricular mass (g) 137.8 ± 98.3 149.1 ± 80.0 <0.001
Left ventricular mass index (g/m2.7) 38.8 ± 27.6 41.0 ± 20.7 <0.001
Prevalence of left ventricular hypertrophy, % 461 (7.9) 551 (12.9) <0.001
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Discussion
The main findings of this large-scale cross-section study
were as follows: Firstly, after adjustment for age, race,
gender, educational status, physical activity, annual in-
come, current smoking status, current drinking status
and sleep duration, snoring and four kinds of snoring
intensity were significantly associated with LVH. Sec-
ondly, when we further adjusted for the metabolic
factors, snoring, normal, strong and very strong snor-
ing intensity, but not low snoring intensity, were sig-
nificantly associated with LVH. However, the ORs
which evaluate the association between snoring, snor-
ing intensity and LVH were attenuated. This suggests
that metabolic factors partly mediate the association
between snoring, snoring intensity and LVH. Finally,
with the increase in snoring intensity, snoring was in-
creasingly risky to LVH. Also we found that the
prevalence of LVH increased significantly with the
rise in snoring intensity.
Epidemiologic studies have showed that snoring is
significantly associated with the development of CVD
[3–6]. However, As far as we know, this is the first
study to show that snoring is signifacantly associated
with LVH in the general population, and also the first
to probe into the effect of varying degrees of snoring
intensity on CVD. The biological mechanisms that
link snoring to LVH remain to be fully elucidated,
but some of mechanisms have been proposed. we
know that some of the snorers are often accompanied
by OSA. It has been verified in relevant studies that
OSA constitutes an important risk factor of ventricu-
lar remodeling [23, 24]. OSA can reduce the oxygen
saturation indices and cause acute sympathetic activa-
tion, hemodynamic change and platelet aggregation,
which increase cardiac output and induce ventricular
remodeling. This is one of the reasons why snoring
can lead to LVH. Previous studies showed particular
interest in the relationship between OSA and ven-
tricular remodeling; however, the detection of OSA
has to use polysomnography. As a result, only a
handful of subjects were involved in the studies, far
from being persuasive. Compared with OSA, snoring
can be used for questionnaire survey to collect data
and suitable for large-scale epidemiological investiga-
tions [3–6]. In addition, snorers capture snoring
symptoms experienced over time, which cannot be ac-
quired by overnight measurement [11].
Metabolic disorder is another probable way of mediat-
ing the association between snoring and LVH. In the
present study, compared with non-snorers, snorers ap-
pear to be more obese, hypertensive, hyperlipemia and
diabetic, and the ORs which evaluate the association be-
tween snoring, snoring intensity and LVH were attenu-
ated when we further adjusted for these metabolic
factors. This suggests that metabolic disorders partly
mediate the association between snoring and LVH. As is
known to us that hypertension ranks among the most
important risk factors of LVH [25]. What’s more, it has
been reported in relevant studies that snoring serves as
an important independent risk factor of hypertension
[26, 27]. Liang Sun [7] showed that snoring, independent
of lifestyle factors, adiposity, inflammatory markers and
adipokines in apparently healthy Chinese, was signifi-
cantly associated with metabolic syndrome. And it has
been verified in numerous studies that metabolic syn-
drome is an important risk factor of LVH. Mats Halldin
proved in his study [28] that high blood pressure and
WC were independent risk factors for LVH and argued
Table 3 Multiple regression analyses for the relationship between snoring status, snoring intensity and left ventricular hypertrophy
Model 1 Model 2 Model 3
OR (95 % CI) P OR (95 % CI) P OR (95 % CI) P
Snoring status
Non-snorers 1.000 (reference) 1.000 (reference) 1.000 (reference)
Snorers 1.734 (1.522–1.976) <0.001 1.709 (1.495–1.953) <0.001 1.371 (1.147–1.637) <0.001
Snoring intensity
Non-snorers 1.000 (reference) 1.000 (reference) 1.000 (reference)
Low 1.352 (1.111–1.644) 0.003 1.381 (1.131–1.687) 0.002 1.094 (0.834–1.434) 0.518
Normal 1.767 (1.477–2.115) <0.001 1.774 (1.476–2.133) <0.001 1.436 (1.126–1.832) 0.004
Strong 2.025 (1.666–2.460) <0.001 1.886 (1.545–2.302) <0.001 1.462 (1.124–1.902) <0.001
Very strong 2.344 (1.745–3.149) <0.001 2.199 (1.624–2.977) <0.001 1.813 (1.273–2.684) <0.001
Model 1: unadjusted
Model 2: adjusted for age, race, gender, educational status, physical activity, annual income, current smoking status, current drinking status and sleep duration
Model 3: adjusted for model 1 plus hypertension, body mass index, waist circumference, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,
triglyceride, total cholesterol and fasting plasma glucose
CI confidence interval, OR Odds ratio
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that the LVH might result from the changes in the medi-
ated IGF-1 and IGF-Binding Protein-1. Halldin M [29]
proved that it was high blood pressure, abdominal obes-
ity and high glucose levels (only limited to in females)
that caused LVH. In view of this, we propose those who
have experienced chronic snoring should be careful
about LVH. Besides, while treating LVH patients with se-
vere snoring, physicians should give appropriate treat-
ment to the snoring of patients.
Nevertheless, there still remains some limitations in
our study. Firstly, as our study is based on cross-
sectional designs, it is unable to distinguish between
cause and effect. Therefore, we propose to verify our
conclusions through relevant cohort studies. Secondly,
our data on snoring and snoring intensity were obtained
from self-report questionnaires, and some subjects living
alone were likely to be unaware of their snoring status.
Misclassification of snoring status might have attenuated
the connection between snoring and LVH, though those
who were unclear of their snoring conditions had been
excluded from the questionnaires. Finally, our study
aims only at Chinese populations. As a result, the
present results may not be applicable to populations
from other regions and ethnic groups.
Conclusion
this large-scale cross-sectional study shows that snoring
is independently associated with LVH. What’s more,
with the rise in snoring intensity, snoring will exert
an increasing effect on LVH.
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